Depani Monal, Ferry Andrew M, Grush Andrew E, Moreno Tanir A, Jones Lloyd M, Thornton James F
Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.
Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Semin Plast Surg. 2021 Dec 31;36(1):26-32. doi: 10.1055/s-0041-1741399. eCollection 2022 Feb.
The unique requirements of reconstructing cheek defects, often with its proximity to the mobile elements of the face including the lip and the eyelid, have been met very handily with the directed and thoughtful use of biologic wound healing agents. One of the key advantages of these agents is their ability to provide coverage for the mobile elements of the cheek and the lip in patients with multiple co-morbidities. These agents are successfully used where the standard cheek closure techniques including cervicofacial advancement flap are contraindicated due to its anesthetic requirement. Additionally, lip reconstruction involves examining the lip's three anatomic layers: mucosa, muscle, and skin. The defects must be planned for reconstruction based on the involvement of these layers. This paper serves to introduce the use of biologic wound healing agents depending on the involvement of these layers. The authors provide specific illustrations of these agents based on defect location, tissue involvement, and severity of the defect to help with procedural planning to reconstruct a very aesthetically involved part of the face.
修复面颊缺损往往有其独特要求，因为它常常靠近面部的活动部位，包括嘴唇和眼睑，而生物伤口愈合剂的定向且周到的使用很好地满足了这些要求。这些药剂的关键优势之一在于，它们能够为患有多种合并症的患者的面颊和嘴唇活动部位提供覆盖。在包括面颈推进皮瓣在内的标准面颊闭合技术因麻醉要求而禁忌使用的情况下，这些药剂得到了成功应用。此外，唇部重建涉及检查唇部的三个解剖层：黏膜、肌肉和皮肤。必须根据这些层的受累情况来规划缺损的重建。本文旨在介绍根据这些层的受累情况使用生物伤口愈合剂。作者根据缺损位置、组织受累情况和缺损严重程度提供了这些药剂的具体示例，以帮助进行手术规划，修复面部一个美学要求很高的部位。
